Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #951

    Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody® Technology Platform against a Pair of Disease Relevant Targets

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #952

      Link Preview Image
      Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

      /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered...

      favicon

      (www.prnewswire.com)

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #953

        Den har været nævnt her før men lyder spændende

        1 Reply Last reply
        0
        • P Offline
          P Offline
          Plimsoller
          wrote on sidst redigeret af
          #954

          God morgen 🙂

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #955

            God morgen. 🙂

            1 Reply Last reply
            0
            • M Offline
              M Offline
              Mogan
              wrote on sidst redigeret af
              #956

              God morgen 🙂

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Stroka
                wrote on sidst redigeret af
                #957

                Ikke megen chat i dag. Kursen klarer sig heldigvis fint uden. 🙂

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #958

                  DAX går pænt amok: https://www.proinvestor.com/investornyt/667649/dax-future-brager-op-gennem-12800-nu-3-i-dag

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #959

                    Large new ECOG-ACRIN trial, Dara Len Dex, adding Bortezomib in the consolidation phase only https://clinicaltrials.gov/ct2/show/NCT04566328?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=09%2F28%2F2020&draw=2&rank=3

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #960

                      A third wing of the biotech is working on protein-based therapies, including in programs that pair its technology with the potentially complementary capabilities of CRISPR Therapeutics and Genmab.

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #961

                        Just a moment...

                        favicon

                        (www.fiercebiotech.com)

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #962

                          Det var vel slet ikk så ring en daw. 😉

                          1 Reply Last reply
                          0
                          • nohopeN Offline
                            nohopeN Offline
                            nohope
                            wrote on sidst redigeret af
                            #963

                            Lidt har også ret.

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #964

                              Det er super positivt, at vi nærmer os 2400. Der er ganske pæn underliggende styrke. Gad nok vide hvem der maser på og med hvilken begrundelse, som ikke analytikerne har fået øje på.

                              1 Reply Last reply
                              0
                              • T Offline
                                T Offline
                                transalp
                                wrote on sidst redigeret af
                                #965

                                Go morgen.. 🙂

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #966

                                  God morgen. :-). FDA has granted PR for bb2121. https://www.onclive.com/view/fda-grants-priority-review-to-ide-cel-for-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=9-28-20_GIL-20-OGD0761_OncLiveSS_NHL CC eNews_Zydelig,Gilead_NON_US_Send&eKey=

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #967

                                    Vincent Rajkumar
                                    @VincentRK
                                    Just out: Current Treatment Algorithms for Multiple Myeloma. Concise Guide to Treatment in Open Access Resource. Blood Cancer Journal. #BCJ @myelomaMD
                                    @MayoClinic
                                    @mtmdphd
                                    @MayoCancerCare
                                    @Rfonsi1
                                    @NorthTxMSG
                                    #myelomaVR

                                    Full Text: https://nature.com/articles/s41408-020-00359-2

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #968

                                      Flot comeback - mon det igen fokus rettes på den snart ekstremt flotte pipeline og høje forhåbninger til specielt PD-L1/4-1BB

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #969

                                        Mon ikke DuoBody platformen gør os stor glæde i de kommende år - synes mere og mere den viser sit værd. Glæder mig mere til mere til indsigt i alt hvad der foregår på CMD i november.

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #970

                                          Enig Sukker.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger